Paper9490707
Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA.
Grass JA and 6 others. Blood, 1998. Cited by 132 papers, by iCite.
Cite this record
ConductScience Library. Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA. Papers, record 9490707. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9490707
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graft vs Host Disease | Major topic |
| Leukocytes | Major topic |
| Methoxsalen | Major topic |
| Photosensitizing Agents | Major topic |
| Plateletpheresis | Major topic |
| Trioxsalen | Major topic |
| Ultraviolet Rays | Major topic |
| Adult | |
| DNA Adducts | |
| DNA Damage | |
| Gamma Rays | |
| Humans | |
| Interleukin-8 | |
| Leukocyte Count | |
| Photochemistry | |
| Platelet Transfusion | |
| Polymerase Chain Reaction | |
| T-Lymphocytes |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| HL 43320 | NHLBI NIH HHS | United States | R01HL043320 | PubMed and NIH |
Source NIH RePORTER
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38416722 | The effect of UVA light/8-methoxypsoralen exposure used in Extracorporeal Photopheresis treatment on platelets and extracellular vesicles. | PLoS One | 2024 | https://conductscience.org/library/papers/38416722 | PubMed |
| 35808974 | Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storage. | Transfusion | 2022 | https://conductscience.org/library/papers/35808974 | PubMed |
| 33879794 | Optimized photochemistry enables efficient analysis of dynamic RNA structuromes and interactomes in genetic and infectious diseases. | Nat Commun | 2021 | https://conductscience.org/library/papers/33879794 | PubMed |
| 32708843 | Inactivated Platelet Lysate Supports the Proliferation and Immunomodulant Characteristics of Mesenchymal Stromal Cells in GMP Culture Conditions. | Biomedicines | 2020 | https://conductscience.org/library/papers/32708843 | PubMed |
| 32333396 | Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light. | Transfusion | 2020 | https://conductscience.org/library/papers/32333396 | PubMed |
| 31437439 | Understanding cornea homeostasis and wound healing using a novel model of stem cell deficiency in Xenopus. | Exp Eye Res | 2019 | https://conductscience.org/library/papers/31437439 | PubMed |
| 30883807 | How do we … integrate pathogen reduced platelets into our hospital blood bank inventory? | Transfusion | 2019 | https://conductscience.org/library/papers/30883807 | PubMed |
| 29931520 | Pathogen-Inaktivierungssysteme für Thrombozytenkonzentrate : Stellungnahme. | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz | 2018 | https://conductscience.org/library/papers/29931520 | PubMed |
| 29130190 | PARIS: Psoralen Analysis of RNA Interactions and Structures with High Throughput and Resolution. | Methods Mol Biol | 2018 | https://conductscience.org/library/papers/29130190 | PubMed |
| 28763452 | Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells. | PLoS One | 2017 | https://conductscience.org/library/papers/28763452 | PubMed |
| 28756627 | Pathogen-reduced platelets for the prevention of bleeding. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28756627 | PubMed |
| 25369598 | In vitro evaluation of pathogen-inactivated buffy coat-derived platelet concentrates during storage: psoralen-based photochemical treatment step-by-step. | Blood Transfus | 2015 | https://conductscience.org/library/papers/25369598 | PubMed |
| 24529555 | Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions. | Cytotherapy | 2014 | https://conductscience.org/library/papers/24529555 | PubMed |
| 23530077 | Photochemical inactivation of chikungunya virus in human apheresis platelet components by amotosalen and UVA light. | Am J Trop Med Hyg | 2013 | https://conductscience.org/library/papers/23530077 | PubMed |
| 21779203 | Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System™ | Transfus Med Hemother | 2011 | https://conductscience.org/library/papers/21779203 | PubMed |
| 21474358 | [Photochemical inactivation of pathogens in platelets and plasma: five years of clinical use in routine and hemovigilance. Towards a change of paradigm in transfusion safety]. | Transfus Clin Biol | 2011 | https://conductscience.org/library/papers/21474358 | PubMed |
| 21245977 | 11 Adverse Reactions. | Transfus Med Hemother | 2009 | https://conductscience.org/library/papers/21245977 | PubMed |
| 20737011 | Annexin V Release and Transmembrane Mitochondrial Potential during Storage of Apheresis-Derived Platelets Treated for Pathogen Reduction. | Transfus Med Hemother | 2010 | https://conductscience.org/library/papers/20737011 | PubMed |
| 19682337 | Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment. | Transfusion | 2009 | https://conductscience.org/library/papers/19682337 | PubMed |
| 19617907 | Irradiation eradication and pathogen reduction. Ceasing cesium irradiation of blood products. | Bone Marrow Transplant | 2009 | https://conductscience.org/library/papers/19617907 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CXCL8 | 3576 | PubTator's text mining | https://conductscience.org/library/genes/3576 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9490707
GET https://conductscience.org/api/papers/v1/9490707/cited_by?page=2